Takeda Pharmaceutical Co LtdNYSE:TAK
No Matches were found for
- LAST PRICE16.4800
- TODAY'S CHANGE (%)0.1300 (0.7951%)
- Bid / Lots16.0000/ 1
- Ask / Lots16.5300/ 2
- Open / Previous Close16.3500 / 16.3500
- Day Range
- 52 Week Range
- Volume1,665,447
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Select an index
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TAK |
|---|---|---|
| 09:32 ET | 36370 | 16.4 |
| 09:34 ET | 20765 | 16.43 |
| 09:36 ET | 6008 | 16.435 |
| 09:38 ET | 21127 | 16.44 |
| 09:39 ET | 10505 | 16.45 |
| 09:41 ET | 9060 | 16.44 |
| 09:43 ET | 5290 | 16.42 |
| 09:45 ET | 4878 | 16.45 |
| 09:48 ET | 5790 | 16.445 |
| 09:50 ET | 47466 | 16.445 |
| 09:52 ET | 5989 | 16.45 |
| 09:54 ET | 13547 | 16.469 |
| 09:56 ET | 6500 | 16.47 |
| 09:57 ET | 17836 | 16.465 |
| 09:59 ET | 3875 | 16.465 |
| 10:01 ET | 12523 | 16.475 |
| 10:03 ET | 8889 | 16.47 |
| 10:06 ET | 16565 | 16.49 |
| 10:08 ET | 2146 | 16.485 |
| 10:10 ET | 5392 | 16.5 |
| 10:12 ET | 2700 | 16.499 |
| 10:14 ET | 17601 | 16.475 |
| 10:15 ET | 4846 | 16.46 |
| 10:17 ET | 1500 | 16.46 |
| 10:19 ET | 4319 | 16.465 |
| 10:21 ET | 2231 | 16.47 |
| 10:24 ET | 6833 | 16.47 |
| 10:26 ET | 69892 | 16.475 |
| 10:28 ET | 36246 | 16.46 |
| 10:30 ET | 9775 | 16.445 |
| 10:32 ET | 16995 | 16.47 |
| 10:33 ET | 32948 | 16.47 |
| 10:35 ET | 24154 | 16.46 |
| 10:37 ET | 225 | 16.455 |
| 10:39 ET | 10282 | 16.46 |
| 10:42 ET | 1314 | 16.465 |
| 10:44 ET | 19865 | 16.47 |
| 10:46 ET | 530 | 16.47 |
| 10:48 ET | 2221 | 16.47 |
| 10:50 ET | 17595 | 16.47 |
| 10:51 ET | 6689 | 16.45 |
| 10:53 ET | 1600 | 16.45 |
| 10:55 ET | 4330 | 16.45 |
| 10:57 ET | 2625 | 16.46 |
| 11:00 ET | 3399 | 16.465 |
| 11:02 ET | 1352 | 16.465 |
| 11:04 ET | 13797 | 16.46 |
| 11:06 ET | 500 | 16.46 |
| 11:08 ET | 5359 | 16.4501 |
| 11:09 ET | 4756 | 16.455 |
| 11:11 ET | 1964 | 16.455 |
| 11:13 ET | 5316 | 16.46 |
| 11:15 ET | 100 | 16.465 |
| 11:18 ET | 2047 | 16.465 |
| 11:20 ET | 5083 | 16.465 |
| 11:22 ET | 2231 | 16.465 |
| 11:24 ET | 2280 | 16.47 |
| 11:26 ET | 584 | 16.465 |
| 11:27 ET | 10142 | 16.47 |
| 11:29 ET | 30529 | 16.47 |
| 11:31 ET | 1100 | 16.47 |
| 11:33 ET | 2798 | 16.47 |
| 11:36 ET | 600 | 16.47 |
| 11:38 ET | 2300 | 16.469 |
| 11:40 ET | 7884 | 16.47 |
| 11:42 ET | 200 | 16.47 |
| 11:44 ET | 2000 | 16.47 |
| 11:45 ET | 5715 | 16.48 |
| 11:47 ET | 13708 | 16.475 |
| 11:49 ET | 8050 | 16.465 |
| 11:51 ET | 10539 | 16.465 |
| 11:54 ET | 1297 | 16.465 |
| 11:56 ET | 1900 | 16.47 |
| 11:58 ET | 100 | 16.47 |
| 12:02 ET | 900 | 16.47 |
| 12:03 ET | 1800 | 16.465 |
| 12:05 ET | 2000 | 16.469 |
| 12:07 ET | 900 | 16.47 |
| 12:09 ET | 3962 | 16.4694 |
| 12:12 ET | 1176 | 16.469 |
| 12:14 ET | 1120 | 16.469 |
| 12:16 ET | 1112 | 16.47 |
| 12:18 ET | 600 | 16.47 |
| 12:20 ET | 5759 | 16.4627 |
| 12:21 ET | 4979 | 16.48 |
| 12:23 ET | 100 | 16.48 |
| 12:25 ET | 1492 | 16.48 |
| 12:27 ET | 13540 | 16.475 |
| 12:30 ET | 2194 | 16.475 |
| 12:32 ET | 16313 | 16.465 |
| 12:34 ET | 5435 | 16.47 |
| 12:36 ET | 2204 | 16.47 |
| 12:38 ET | 11152 | 16.47 |
| 12:39 ET | 4057 | 16.47 |
| 12:41 ET | 2458 | 16.465 |
| 12:43 ET | 30898 | 16.48 |
| 12:45 ET | 7568 | 16.475 |
| 12:48 ET | 100 | 16.475 |
| 12:50 ET | 1300 | 16.475 |
| 12:52 ET | 29238 | 16.485 |
| 12:54 ET | 7231 | 16.485 |
| 12:56 ET | 10530 | 16.5 |
| 12:57 ET | 11227 | 16.5 |
| 12:59 ET | 17027 | 16.495 |
| 01:01 ET | 3696 | 16.5 |
| 01:03 ET | 25318 | 16.485 |
| 01:06 ET | 738 | 16.485 |
| 01:08 ET | 14569 | 16.485 |
| 01:10 ET | 1020 | 16.48 |
| 01:12 ET | 100 | 16.48 |
| 01:14 ET | 5301 | 16.475 |
| 01:15 ET | 1797 | 16.47 |
| 01:17 ET | 5755 | 16.4634 |
| 01:19 ET | 100 | 16.465 |
| 01:21 ET | 495 | 16.46 |
| 01:24 ET | 3500 | 16.46 |
| 01:26 ET | 200 | 16.465 |
| 01:28 ET | 15485 | 16.45 |
| 01:30 ET | 2122 | 16.45 |
| 01:32 ET | 2651 | 16.455 |
| 01:33 ET | 4207 | 16.445 |
| 01:35 ET | 905 | 16.4464 |
| 01:37 ET | 606 | 16.4469 |
| 01:42 ET | 4404 | 16.45 |
| 01:44 ET | 928 | 16.45 |
| 01:46 ET | 564 | 16.445 |
| 01:48 ET | 300 | 16.445 |
| 01:50 ET | 1614 | 16.445 |
| 01:51 ET | 253 | 16.45 |
| 01:53 ET | 4574 | 16.45 |
| 01:55 ET | 669 | 16.445 |
| 01:57 ET | 400 | 16.45 |
| 02:00 ET | 900 | 16.45 |
| 02:02 ET | 1672 | 16.45 |
| 02:04 ET | 100 | 16.45 |
| 02:06 ET | 14296 | 16.455 |
| 02:08 ET | 10817 | 16.455 |
| 02:09 ET | 4249 | 16.45 |
| 02:11 ET | 2052 | 16.455 |
| 02:13 ET | 2890 | 16.455 |
| 02:15 ET | 3052 | 16.455 |
| 02:18 ET | 671 | 16.455 |
| 02:20 ET | 700 | 16.46 |
| 02:22 ET | 3616 | 16.46 |
| 02:24 ET | 12785 | 16.455 |
| 02:26 ET | 852 | 16.455 |
| 02:27 ET | 16871 | 16.44 |
| 02:29 ET | 2500 | 16.445 |
| 02:31 ET | 1970 | 16.445 |
| 02:33 ET | 5012 | 16.46 |
| 02:36 ET | 1732 | 16.45 |
| 02:38 ET | 600 | 16.46 |
| 02:42 ET | 338 | 16.4551 |
| 02:44 ET | 3782 | 16.465 |
| 02:45 ET | 400 | 16.47 |
| 02:47 ET | 11758 | 16.47 |
| 02:49 ET | 4104 | 16.48 |
| 02:51 ET | 2581 | 16.475 |
| 02:54 ET | 1290 | 16.48 |
| 02:56 ET | 4288 | 16.48 |
| 02:58 ET | 2363 | 16.48 |
| 03:00 ET | 300 | 16.475 |
| 03:02 ET | 2784 | 16.48 |
| 03:03 ET | 12999 | 16.485 |
| 03:05 ET | 3668 | 16.485 |
| 03:07 ET | 23240 | 16.47 |
| 03:09 ET | 733 | 16.47 |
| 03:12 ET | 4775 | 16.475 |
| 03:14 ET | 29760 | 16.485 |
| 03:16 ET | 25331 | 16.475 |
| 03:18 ET | 3593 | 16.475 |
| 03:20 ET | 7364 | 16.47 |
| 03:21 ET | 3080 | 16.475 |
| 03:23 ET | 2756 | 16.475 |
| 03:25 ET | 3894 | 16.48 |
| 03:27 ET | 998 | 16.48 |
| 03:30 ET | 500 | 16.4796 |
| 03:32 ET | 9149 | 16.485 |
| 03:34 ET | 2150 | 16.485 |
| 03:36 ET | 2705 | 16.49 |
| 03:38 ET | 26328 | 16.465 |
| 03:39 ET | 3370 | 16.465 |
| 03:41 ET | 9153 | 16.465 |
| 03:43 ET | 1051 | 16.465 |
| 03:45 ET | 6402 | 16.465 |
| 03:48 ET | 18440 | 16.46 |
| 03:50 ET | 5930 | 16.46 |
| 03:52 ET | 7636 | 16.47 |
| 03:54 ET | 27004 | 16.46 |
| 03:56 ET | 47953 | 16.475 |
| 03:57 ET | 18966 | 16.475 |
| 03:59 ET | 113214 | 16.48 |
Mar 31, 2023
Hutchmed Completes Rolling Submission of New Drug Application for Colorectal Cancer Drug Candidate in the US, from 4:17AM ET on Friday Mar 31, 2023 by MT Newswires
4:17AM ET on Friday Mar 31, 2023 by MT Newswires
Mar 30, 2023
HUTCHMED Completes Rolling Submission of NDA to U.S. FDA for Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer, from 8:00PM ET on Thursday Mar 30, 2023 by GlobeNewswire
8:00PM ET on Thursday Mar 30, 2023 by GlobeNewswireSector Update: Healthcare Stocks Mostly Higher Late Thursday, from 3:56PM ET on Thursday Mar 30, 2023 by MT Newswires
3:56PM ET on Thursday Mar 30, 2023 by MT NewswiresTakeda Pharmaceutical Says Phase 4 Trial of Chronic Pouchitis Drug Meets Primary Endpoint, from 1:00PM ET on Thursday Mar 30, 2023 by MT Newswires
1:00PM ET on Thursday Mar 30, 2023 by MT NewswiresTakeda Announces Results From Phase 4 Vedolizumab Study in Patients With Chronic Pouchitis Published in New England Journal of Medicine, from 7:00AM ET on Thursday Mar 30, 2023 by Business Wire
7:00AM ET on Thursday Mar 30, 2023 by Business Wire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Takeda Pharmaceutical Co Ltd | 51.9B | 24.9x | -0.05% |
Thorne Healthtech Inc | 244.1M | 38.0x | --- |
Assertio Holdings Inc | 354.0M | 3.6x | --- |
Evolus Inc | 477.2M | -6.4x | --- |
Bavarian Nordic A/S | 2.2B | 0.0x | --- |
Lifecore Biomedical Inc | 114.5M | -1.3x | --- |
Company Information
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.
Contact Information
- Headquarters
- 4F, 2-1-1, Nihombashihon-choCHUO-KU, TKY, Japan 103-8668
- Phone
- ---
- Fax
- ---
Executives
- Chairman of Board of Directors, Independent Director
- Masami Iijima
- President, Chief Executive Officer, Representative Director
- Christophe Weber
- Chief Financial Officer, Director
- Costa Saroukos
- President of Research & Development, Vice President of Subsidiary, Director
- Andrew Plump
- Representative Director
- Masato Iwasaki
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $51.9B |
|---|---|
Revenue (TTM) | $29.7B |
Shares Outstanding | 3.2B |
Dividend Yield | 6.41% |
Annual Dividend Rate | 1.0565 USD |
Ex-Dividend Date | 09-28-22 |
Pay Date | 12-12-22 |
Beta | 0.66 |
EPS | $0.66 |
Book Value | $13.80 |
P/E Ratio | 24.9x |
Price/Sales (TTM) | 1.7 |
Price/Cash Flow (TTM) | 7.4x |
Operating Margin | 10.15% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
